Stelerix Web Blog Knowledge at your Fingertips

15Feb/110

KOL Engagement and Alignment.

Here's a quick excerpt from our Special Comprehensive Country Report, India. It's something we've seen addressed again and again in our follow-up interviews.  I've also thrown in a YouTube interview with Tushar Barad who talks about some of the intricacies of engaging with KOLs.

The updated report will be exclusively available for free through our great friends over at pharmaphorum. So you better get registered!

"Respondents identified active engagement of local Key Opinion Leaders as the most effective means to understand their needs. Further, this strategy provides accurate insight into actual affordability as demonstrated by purchasing power and cost of living, in addition to possible commercial strategies and their respective likelihoods. However, our research also suggested that organizations as a whole have been slow to actively engage end-users. Patience and value on the long term was also a key trend among respondents. It was evident from our results that success in India favors ongoing and long-term relationships that grow and evolve over time. While short-term profit can be made, it is clear that the initial time investment and requisite patience were rewarded many times over when focus was placed on the longer term.  A further benefit of continuous investment in “relationship capital” is the evolution of mutually business partnerships. Organizations who establish themselves effectively in India can often leverage their presence to reach other fast-growing markets in the South-Asian and Asia-Pacific region. Our experts agree that to be effective into 2020 and beyond, market leaders must invest proactively in nascent relationships, given the propensity for longer cycle time in such business partnerships. Opportunity to cut costs and drive access will exist for those who look to partner and aid, rather than exploit."

Posted by Jeff

Oh yeah, the full report will also be available for download here, but this week only!!

10Feb/110

Feature: Swami Samarth Pharmatech

We've got another interview up! Check out our exclusive feature with the owner of Mumbai-based Swami Samarth Pharmatech, Nitin Parab. He talks about what's necessary for success in

We're also hosting the web version of Nitin's upcoming event "Gateway to Europe, for Medical Devices."

We are lucky to have the partners we do.

Posted by Jeff

Posted by Jeff

8Feb/110

Funding Initiatives and Analytical Applications.

As promised, here is the full summary and video transcript of my recent interview with Dr. Gregory Weiss.

Feel free to submit follow-up questions or start a discussion.

If you want to contribute to an upcoming interview or suggest someone as a candidate because of interesting thought-leading work, please contact us or leave a comment here!

Posted by Jeff

4Feb/110

Input in Action.

Thank you for the ongoing feedback. We are always growing, learning, and evolving. We appreciate hearing about how you think we might be able to do things a little bit better.

Today's update is regarding the library section of the main site. We've organized it into particular portals, organized by specific verticals that are of focus and interest to us. This was a change mandated by end-user input. Thanks for making our site easier to navigate and more engaging. We will continue to listen and implement your suggestions.

Check it out!

We have more changes in the pipeline and will update you here, as it happens!

Posted by Jeff

2Feb/110

Health Biz India

I was lucky to get a great picture of the rapidly growing healthcare scene in India in my recent correspondence with Jayata Sharma, the Editor-in-Chief of Health Biz India.

As we've seen mentioned before, it was emphasized again that key opinion leaders are absolutely critical to progress and understanding of market conditions within India.

Inform yourself about Indian healthcare's first B2B news portal. Read this interview.

28Jan/110

Value-Added Generics

I appreciate your patience in bearing with me in the last few weeks. As you undoubtedly know, I've been busy populating the library section of the main site. I am making a lot of progress, and there is even more in the pipeline.

One of the challenges has been ensuring high-quality audio. Much to my initial dismay, the sound-quality suffered on the first few recordings. For enduring this, I am grateful. After much experimentation I have found a methodology for getting things online relatively quickly and at high-fidelity.

I'm also picking out parts that I thought were of particular value. Here's a clip from Atul Sharma, talking about the importance of innovation in value-added generics.

Posted by Jeff

27Jan/110

Achieving Buy-In

I spoke with Vivek Shukla about his astounding success in pharmaceutical business strategy in India, over the last 12 years.

We talked about this success philosophy, how to leverage human capital, and how to get buy-in from stakeholders. I am working on getting the entire interview up on the main site as quickly as possible. But for now here's a little trailer. I asked Vivek what the biggest challenge was when it came to getting buy-in and alignment of vision. Enjoy!

Posted by Jeff

21Jan/110

It’s Ongoing.

Thanks for sticking with us. The exciting growth, over the in the library, has come somewhat at the extent of this Blog. But fear not, loyal reader. Our gradual improvement is an ongoing thing. Think of us as a value investment, good valuation (free!) and which will yield dividends over time.

We have a lot of exciting things in the pipeline, including some changes under the hood. And it's only going to get better.

In addition to technological steps forward, we perpetually reexamine and refine our ability to consistently provide high quality on-demand knowledge solutions. Our competitive advantage is in leveraging proprietary processes and a network of hands-on leaders in an array of global markets, for cost-effective, premium knowledge deliverables. We are always narrowing in on our specifically targeted verticals. We continue to grow partnerships with niche and industry specific leading content producers and distributors. Meanwhile, our in-house marketing, production, and primary research efforts sustain our unique and cutting-edge outlook; we integrate robust and renowned thought content and our own proprietary yet comprehensive gauge of industry sentiment, to bring well-contrasted strategies into sight.

For success, stay with us. It has come in incremental steps. And will continue to do so. With a minor setback or two along the way, of course. But like the Dow Jones, circa March 2009 to now, it'll be mostly up.

Posted by Jeff

18Jan/110

Exclusive On-Demand Webinar, Free! Atul Sharma – Global Partnerships

If you have not yet read or listened, check this out!

Atul Sharma, Senior Manager at Alembic Limited took some time to speak with me about his expansive experiences in a diverse array of emerging and mature markets.

We discuss a number of issues in-depth, like understanding local success drivers and why innovation is especially important in generic formulations.

There are lots more similar interviews coming up, so submit your questions if you want to hear from experts!

Posted by Jeff

11Jan/110

Local Savvy

Here's an excerpt from our recent premium research:

"Of course, respondents identified active engagement of local people as the most effective means to understand their respective needs, as well as what they are able to pay to address them. However, our research also suggested that organizations as a whole have been slow to engage end-users actively. Patience and value on the long term was also a key trend among respondents. It was evident from our results that success in India favors ongoing and long-term relationships that grow and evolve over time. It is clear that the initial time investment and requisite patience were rewarded many times over in the longer term"

It's interesting, given some recent developments in the news.

Despite minor analytical shortcomings, the researchers identified different factors influencing prescription in a number of regions. It's evident that local stakeholder engagement is critical as our research said.

Alternatively, big pharma can continue to acquire leading domestic players. Abbott complemented it's own internal efforts by buying up Piramal. It plans to let the business operate independently with current management; a robust strategy, judging by our research.

We touch more on the subject of how to successfully partner with local influences and key opinion leaders in our follow-up interview with Alok Kumar (original here). It will be an audio presentation supplemented with powerpoint slides, available soon!

Sign up for our newsletter to be kept up to date!

Posted by Jeff

Page 1 of 212